Peter Bläuenstein
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Monoclonal and Polyclonal Antibodies Research
- Oncology top 5%
- Peptidase Inhibition and Analysis
Papers in ⓘ
-
- Radiopharmaceutical Chemistry and Applications 35
- Medical Imaging Techniques and Applications 9
- Monoclonal and Polyclonal Antibodies Research 7
- Oncology 18
- Peptidase Inhibition and Analysis 12
- Lung Cancer Research Studies 5
- Co-authors
- P. August Schubiger (26 shared papers)Dirk Tourwé (19 shared papers)Elisa García‐Garayoa (12 shared papers)Véronique Maes (10 shared papers)Elisa Garcı́a Garayoa (10 shared papers)Alain Blanc (10 shared papers)Roger Schibli (12 shared papers)Annette G. Beck‐Sickinger (4 shared papers)
- Journals
- Nuclear Medicine and Biology (8 papers)Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry (4 papers)Bioconjugate Chemistry (3 papers)European Journal of Nuclear Medicine and Molecular Imaging (3 papers)Applied Radiation and Isotopes (2 papers)
- Partner nations
- SwitzerlandBelgiumGermany
In The Last Decade
Peter Bläuenstein
52 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 102
- Radiology, Nuclear Medicine and Imaging 951
- Oncology 646
- Cellular and Molecular Neuroscience 310
- Epidemiology 311
- Pulmonary and Respiratory Medicine 262
Countries citing papers authored by Peter Bläuenstein
This map shows the geographic impact of Peter Bläuenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bläuenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bläuenstein more than expected).
Fields of papers citing papers by Peter Bläuenstein
This network shows the impact of papers produced by Peter Bläuenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bläuenstein. The network helps show where Peter Bläuenstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Bläuenstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 81 | |
| 2 | 2008 | 81 | |
| 3 | 2001 | 80 | |
| 4 | Radiolabeled neurotensin analog, 99mTc-NT-XI, evaluated in ductal pancreatic adenocarcinoma patients. | 2003 | 80 |
| 5 | 2002 | 78 | |
| 6 | 2006 | 74 | |
| 7 | 2005 | 72 | |
| 8 | 1995 | 70 | |
| 9 | 2008 | 61 | |
| 10 | Preclinical evaluation of a new, stabilized neurotensin(8--13) pseudopeptide radiolabeled with (99m)tc. | 2002 | 58 |
| 11 | 2002 | 55 | |
| 12 | Measurement of the extracellular space in brain tumors using 76Br-bromide and PET. | 2003 | 55 |
| 13 | 2008 | 51 | |
| 14 | 1980 | 46 | |
| 15 | New [99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors. | 2007 | 43 |
| 16 | 2006 | 43 | |
| 17 | 2006 | 40 | |
| 18 | 1975 | 31 | |
| 19 | 1999 | 30 | |
| 20 | Radioimmunolocalization of neuroblastoma xenografts with chimeric antibody chCE7. | 1992 | 28 |
About Peter Bläuenstein
Peter Bläuenstein is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Epidemiology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 52 papers that have together received 1.5k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (35 papers), Peptidase Inhibition and Analysis (12 papers), Neuroendocrine Tumor Research Advances (11 papers), Medical Imaging Techniques and Applications (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Medical Imaging and Pathology Studies (6 papers), Lung Cancer Research Studies (5 papers) and Neuropeptides and Animal Physiology (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (951 citations), Oncology (646 citations), Cellular and Molecular Neuroscience (310 citations), Epidemiology (311 citations) and Pulmonary and Respiratory Medicine (262 citations). Peter Bläuenstein has collaborated with scholars based in Switzerland, Belgium and Germany. Frequent co-authors include P. August Schubiger, Dirk Tourwé, Elisa García‐Garayoa, Véronique Maes, Elisa Garcı́a Garayoa, Alain Blanc, Roger Schibli, Annette G. Beck‐Sickinger, Ilse Novak‐Hofer and G. Anderegg. Their work appears in journals such as Nuclear Medicine and Biology, Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry, Bioconjugate Chemistry, European Journal of Nuclear Medicine and Molecular Imaging and Applied Radiation and Isotopes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.